Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade
More News related to AZ
- Beacon's Fixed Annuity Premium Study Reports Fourth Quarter's Fixed Annuity Sales
- Allianz Life Reports Solid Operating Profits and Premium for 2009
- Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade
- Bank of American Downgrades Allianz (AZ) to Neutral
- J.P. Morgan Upgrades Allianz (AZ) to Overweight
More News related to BHI
- Baker Hughes and BJ Services Adjourn Respective Special Meetings of Stockholders; Meetings to Reconvene on March 31, 2010
- Oppenheimer Initiates Coverage on Several Oil Well Services and Equipment Stocks
- Baker Hughes (BHI) and BJ Services (BJS) Receive Merger Approvals from All Foreign Jurisdictions
- Baker Hughes and BJ Services Comment on the Status of the Pending BJ Services Merger
- Baker Hughes (BHI) Announces Increase in Rig Count for February 2010
More News related to BJS
- Baker Hughes and BJ Services Adjourn Respective Special Meetings of Stockholders; Meetings to Reconvene on March 31, 2010
- S&P Announces Changes to Indices
- Standard & Poor's Announces Changes to U.S. Indices
- After-Hours Movers 3/18: APPA, POL, LOOK Higher; ADUS, PALM, TISI, SPWRA, NLST Lower
- S&P Announces Changes to US Indices: CERN for BJS, MD for MSTR
UPGRADES:
Fox-Pitt upgrades JPMorgan Chase (NYSE: JPM) from In-line to Outperform. Price target increased to $55 from $38.
UBS upgrades PG&E Corp (NYSE: PCG) from Neutral to Buy.
Citi upgrades Novellus (Nasdaq: NVLS) from Hold to Buy. Price target increased from $19.50 to $27.
Barclays is upgrading Per Pharmaceuticals (NYSE: PRX) to Overweight from Equal Weight with a $30 target (prev. $18). Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades BJ Services (NYSE: BJS) from Hold to Sell. Price target lowered from $16 to $14.
Citi downgrades Baker Hughes (NYSE: BHI) from Hold to Sell. Price target $39.
BofA Merrill Lynch downgrades Charles Schwab (Nasdaq: SCHW) from Buy to Neutral. The firm maintained its $23.50 price target.
Bank of American downgrades Allianz (NYSE: AZ) from Buy to Neutral.
Keefe, Bruyette & Woods downgrades The Travelers Companies (NYSE: TRV) to Market Perform. Price target $51.
Oppenheimer downgrades Lazard Ltd (NYSE: LAZ) from Outperform to Perform. Price target $45.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs resumes coverage on Human Genome Sciences, Inc. (Nasdaq: HGSI) with a Buy rating and $24 price target.
Standpoint Research initiates coverage on Wal-Mart (NYSE: WMT) with a Buy. Price target $60.
Bernstein initiates coverage on Petroleo Brasileiro (Petrobras) (NYSE: PBR) with an Outperform rating. Price target $56.
RBC initiates coverage on Weyerhaeuser (NYSE: WY) with a Sector Perform rating. Price target $38.
Susquehanna initiates coverage on NYSE Euronext (NYSE: NYX) with a Neutral rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.00
-1.84Related Entities
- Keefe, Bruyette & Woods
- UBS
- JPMorgan
- Citi
- Merrill Lynch
- Banc of America
- Lazard
- Fox-Pitt Kelton
- Barclays
- Susquehanna International Group of Companies
- Notable Analyst Rating Changes
- EIM Group
- Life, Style and Real Estate
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
